| | | | | | | | | | |
|
|
| Dockets Entered
On September 5, 2006
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1978N-0065
|
| Skin Bleaching Drug Products
|
|
|
| 1992N-0297
|
| Prescription Drug Marketing Act of 1987, Drug Amds of 1992
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
| 2001D-0489
|
| Establishment & Operation of Clinical Trial Monitoring Comm
|
|
|
| 2005D-0169
|
| Guidance on Useful Written Consumer Medication Information (CMI)
|
|
|
| 2005D-0202
|
| Guidance for Industry on Bar Code Label Requirements; Questions and Answers
|
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| 2006D-0331
|
| Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
|
|
|
| 2006N-0352
|
| Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
|
|
|
| 2006P-0114
|
| Refrain from taking administrative action regarding approval and/or effective date of final approval of any and all ANDAs for a generic version of Metrogel-Vaginal 0.75%
|
|
|
| 2006P-0151
|
| Stay the current approvable letter with conditions of any and all Premarket Applications for silicone gel-filled breast implants
|
|
|
| 2006P-0158
|
| Revoke regulations that provided for the inclusion and addition of sucralose as a non-nutritive sweetener in food
|
|
|
| 2006P-0186
|
| Withdraw new drug application (NDA 21-179) for Renagel Tablets (sevelamer hydrochloride) 400 and 800 mg
|
|
|
| 2006P-0223
|
| Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
|
|
|
| 2006P-0310
|
| Compel the Agency to follow requirements of the Drug Listing Act of 1972
|
|
|
| 2006P-0346
|
| Ban Marketing of Estratest, Estratest H.S. and Syntest D.S. and Syntest H.S. associated with Menopause
|
|
|
| 2006P-0360
|
| Determine that the discontinued formulation of Carbocaine Injection, 3% supplied in 1.8 mL cartridge was not discontinued for safety and efficacy reasons
|
|
|
| 2006P-0364
|
| Reformulation of central nervous system (CNS) stimulant drugs
|
|
|
| 2006P-0365
|
| Citizen Petition Urging FDA to Take Regulatory Action to Safeguard the Public from Violative Dental Devices Distributed by Five Companies, Including Devices Manufactured in Unregistered Facilities and
|
|
|
|
|
|
|
| 1978N-0065
|
| Skin Bleaching Drug Products
|
|
|
| EC 3
|
| Mrs. Peggy Brown
|
| Vol #:
|
| 4
|
|
|
| EC 4
|
| Ms. Parisa Fitz-Henley
|
| Vol #:
|
| 4
|
|
|
| EC 5
|
| Miss. Laura Laine-McInnis
|
| Vol #:
|
| 4
|
|
|
| 1992N-0297
|
| Prescription Drug Marketing Act of 1987, Drug Amds of 1992
|
|
|
| EMC 5
|
| D. McNabb
|
| Vol #:
|
| 10
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
| EMC 649
|
| M. Ruhl
|
| Vol #:
|
| 24
|
|
|
| 2001D-0489
|
| Establishment & Operation of Clinical Trial Monitoring Comm
|
|
|
| EC 18
|
| Mr. Dave Lowe
|
| Vol #:
|
| 2
|
|
|
| 2005D-0169
|
| Guidance on Useful Written Consumer Medication Information (CMI)
|
|
|
| EC 19
|
| Mr. Dave Lowe
|
| Vol #:
|
| 2
|
|
| | | | | | | | |
|
|
| 2005D-0202
|
| Guidance for Industry on Bar Code Label Requirements; Questions and Answers
|
|
|
| EC 5
|
| Mr. Dave Lowe
|
| Vol #:
|
| 1
|
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
|
|
| MO 17
|
| TMJ Implants, Inc., and Robert W. Christensen and Maureen K. Mooney
|
| Vol #:
|
| 6
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| EC 33269
|
| Florida Pharmacy Association
|
| Vol #:
|
| 197
|
|
|
| EC 33270
|
| Ms. Kerry Finn
|
| Vol #:
|
| 197
|
|
|
| EC 33271
|
| Ms. Delma J. Soriano
|
| Vol #:
|
| 197
|
|
|
| EMC 3850
|
| L. Mercury
|
| Vol #:
|
| 195
|
|
|
| EMC 3851
|
| P. Fyne
|
| Vol #:
|
| 195
|
|
|
| EMC 3852
|
| T. Frank
|
| Vol #:
|
| 195
|
|
|
| EMC 3853
|
| C. Benoit
|
| Vol #:
|
| 195
|
|
|
| EMC 3854
|
| K. Dydo
|
| Vol #:
|
| 195
|
|
|
| EMC 3855
|
| N. Joyner
|
| Vol #:
|
| 195
|
|
|
| EMC 3856
|
| J. Jenschke
|
| Vol #:
|
| 195
|
|
|
| EMC 3857
|
| K. Reichert
|
| Vol #:
|
| 195
|
|
|
| EMC 3858
|
| V. Dorris
|
| Vol #:
|
| 195
|
|
|
| EMC 3859
|
| R. Myers
|
| Vol #:
|
| 195
|
|
|
| EMC 3860
|
| C. St. John-Harden
|
| Vol #:
|
| 195
|
|
|
| EMC 3861
|
| E. Barkley
|
| Vol #:
|
| 195
|
|
|
| 2006D-0331
|
| Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
|
|
|
| EC 1
|
| Mr. Darryl Wellinghoff
|
| Vol #:
|
| 1
|
|
|
| 2006N-0352
|
| Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
|
|
|
| EC 1
|
| Ms. Shonagh Home
|
| Vol #:
|
| 3
|
|
|
| EC 2
|
| Ms. Kimela Lanford
|
| Vol #:
|
| 3
|
|
|
| EC 3
|
| Mr. Gary Herring
|
| Vol #:
|
| 3
|
|
|
| EC 4
|
| Mrs. Karen Newman
|
| Vol #:
|
| 3
|
|
|
| EC 5
|
| Mr. Venkat Rangamani
|
| Vol #:
|
| 3
|
|
|
| EC 6
|
| Concerned Citizen : ending mercury in dental work
|
| Vol #:
|
| 3
|
|
|
| EC 7
|
| Ms. Lauri Pruett
|
| Vol #:
|
| 3
|
|
|
| EC 8
|
| Ms. Judy Klien
|
| Vol #:
|
| 3
|
|
|
| EC 9
|
| Mr. Roger Nelson
|
| Vol #:
|
| 3
|
|
|
| EC 10
|
| American Dental Association
|
| Vol #:
|
| 3
|
|
|
| EC 11
|
| American Dental Association
|
| Vol #:
|
| 3
|
|
| | | | | | | |
|
|
| EC 12
|
| American Dental Association
|
| Vol #:
|
| 3
|
|
|
| EC 13
|
| Mrs. Sandra osborne
|
| Vol #:
|
| 3
|
|
|
| EC 14
|
| Dr. B Lafferty
|
| Vol #:
|
| 3
|
|
|
| EC 15
|
| Mr. Steven White DTR
|
| Vol #:
|
| 3
|
|
|
| EC 16
|
| Mrs. Lisa Porter
|
| Vol #:
|
| 3
|
|
|
| EC 17
|
| Mr. Lane Weaver
|
| Vol #:
|
| 3
|
|
|
| EC 18
|
| Ms. RoseMary Volpe
|
| Vol #:
|
| 3
|
|
|
| EC 19
|
| Dr. Pauline Hattemer
|
| Vol #:
|
| 3
|
|
|
| EC 20
|
| Mrs. Diane Harrell
|
| Vol #:
|
| 3
|
|
|
| EC 21
|
| Mr. Max Kane
|
| Vol #:
|
| 3
|
|
|
| EC 22
|
| IAOMT
|
| Vol #:
|
| 4
|
|
|
| EC 23
|
| Mr. Charles Spencer
|
| Vol #:
|
| 3
|
|
|
| EC 24
|
| Univ. of Georgia
|
| Vol #:
|
| 3
|
|
|
| EC 25
|
| Mrs. Teresa Irvin
|
| Vol #:
|
| 3
|
|
|
| EC 26
|
| Mrs. Christine Cave
|
| Vol #:
|
| 3
|
|
|
| EC 27
|
| Ms. Judith Ross
|
| Vol #:
|
| 3
|
|
|
| EC 28
|
| Mrs. Monica Thomas
|
| Vol #:
|
| 3
|
|
|
| EC 29
|
| Ms. Bobby McClintock
|
| Vol #:
|
| 3
|
|
|
| EC 30
|
| Mrs. Diana Green
|
| Vol #:
|
| 3
|
|
|
| EC 31
|
| Mountain View Citizens for Safe Drinking Water
|
| Vol #:
|
| 3
|
|
|
| EC 32
|
| Dr. William Harris
|
| Vol #:
|
| 3
|
|
|
| EC 33
|
| Fluoride Action Network
|
| Vol #:
|
| 3
|
|
|
| EC 34
|
| Mrs. VERNA DISTAD
|
| Vol #:
|
| 3
|
|
|
| EC 35
|
| Mrs. Maggie Overdahl
|
| Vol #:
|
| 3
|
|
|
| EC 36
|
| Citizen Political Activist
|
| Vol #:
|
| 3
|
|
|
| EC 37
|
| Mr. J. Michael Bryan
|
| Vol #:
|
| 3
|
|
|
| EC 38
|
| Ms. Arran Thomson
|
| Vol #:
|
| 3
|
|
|
| EC 39
|
| Mr. Pondurenga Das
|
| Vol #:
|
| 3
|
|
|
| EC 40
|
| Mrs. Michele Badanek
|
| Vol #:
|
| 3
|
|
|
| EC 41
|
| None
|
| Vol #:
|
| 3
|
|
|
| EC 42
|
| Dr. Steve Markus
|
| Vol #:
|
| 3
|
|
|
| EC 43
|
| Mr. Daniel McCamman
|
| Vol #:
|
| 3
|
|
|
| EC 44
|
| Mrs. Diane Sperber
|
| Vol #:
|
| 3
|
|
|
| EC 45
|
| The Photo Shoppe
|
| Vol #:
|
| 3
|
|
|
| EC 46
|
| Mr. Ulf Bengtsson
|
| Vol #:
|
| 3
|
|
|
| EC 47
|
| Dr. Rosemary Fecteau
|
| Vol #:
|
| 3
|
|
|
| EC 48
|
| Wellness Rx, Inc.
|
| Vol #:
|
| 3
|
|
| | | | | | | |
|
|
| EC 49
|
| Dr. Andrew Zakarian
|
| Vol #:
|
| 3
|
|
|
| EC 50
|
| Mrs. Marilyn Hageman
|
| Vol #:
|
| 3
|
|
|
| EC 51
|
| Mothers Against Mercury Amalgam / MAMA
|
| Vol #:
|
| 3
|
|
|
| EC 52
|
| Ms. Carolyn Dohrenwend
|
| Vol #:
|
| 3
|
|
|
| EMC 38
|
| Italian Association for Metals and Biocompatibility Research (A.I.R.M.E.B.)
|
| Vol #:
|
| 2
|
|
|
| EMC 39
|
| H. Downing
|
| Vol #:
|
| 2
|
|
|
| EMC 40
|
| O. Woodward
|
| Vol #:
|
| 2
|
|
|
| EMC 41
|
| T. Danysh
|
| Vol #:
|
| 2
|
|
|
| EMC 42
|
| J. Grossman
|
| Vol #:
|
| 2
|
|
|
| EMC 43
|
| R. Kerger
|
| Vol #:
|
| 2
|
|
|
| EMC 44
|
| V. WIlliams
|
| Vol #:
|
| 2
|
|
|
| EMC 45
|
| B. Levy, DDS
|
| Vol #:
|
| 2
|
|
|
| EMC 46
|
| J. Fritzler
|
| Vol #:
|
| 2
|
|
|
| EMC 47
|
| J. Plumb
|
| Vol #:
|
| 2
|
|
|
| EMC 48
|
| S. Pearce
|
| Vol #:
|
| 2
|
|
|
| EMC 49
|
| D. Joelkers
|
| Vol #:
|
| 2
|
|
|
| EMC 50
|
| S. Holmstrom
|
| Vol #:
|
| 2
|
|
|
| EMC 51
|
| C. Griggs
|
| Vol #:
|
| 2
|
|
|
| EMC 52
|
| T. Nocera, B.S., M.A.
|
| Vol #:
|
| 2
|
|
|
| EMC 53
|
| K. Morris
|
| Vol #:
|
| 2
|
|
|
| EMC 54
|
| L. Pellegrini
|
| Vol #:
|
| 2
|
|
|
| EMC 55
|
| D. Mariano
|
| Vol #:
|
| 2
|
|
|
| EMC 56
|
| L. Piatt, MSN, RN
|
| Vol #:
|
| 2
|
|
|
| EMC 57
|
| Dr. K. Chai
|
| Vol #:
|
| 2
|
|
|
| EMC 58
|
| J. Delgado
|
| Vol #:
|
| 2
|
|
|
| EMC 59
|
| D. Coomer
|
| Vol #:
|
| 2
|
|
|
| EMC 60
|
| Dr. R. McGinn
|
| Vol #:
|
| 2
|
|
|
| EMC 61
|
| No signature
|
| Vol #:
|
| 2
|
|
|
| EMC 62
|
| C. Skipper
|
| Vol #:
|
| 2
|
|
|
| EMC 63
|
| Dr. B. Dawson, DC
|
| Vol #:
|
| 2
|
|
|
| EMC 64
|
| B. Huffman
|
| Vol #:
|
| 2
|
|
|
| EMC 65
|
| J. Delgado
|
| Vol #:
|
| 2
|
|
|
| EMC 66
|
| D. Boone
|
| Vol #:
|
| 2
|
|
|
| EMC 67
|
| B. Shelton, MD
|
| Vol #:
|
| 2
|
|
|
| EMC 68
|
| M. Bernstein, M.D., M.S., J.D.
|
| Vol #:
|
| 2
|
|
|
| EMC 69
|
| W. Glaros, DDS
|
| Vol #:
|
| 2
|
|
|
| EMC 70
|
| J. Marcus
|
| Vol #:
|
| 2
|
|
| | | | | | | | |
|
|
| EMC 71
|
| D. MArtin
|
| Vol #:
|
| 2
|
|
|
| EMC 72
|
| O. Duke
|
| Vol #:
|
| 2
|
|
|
| EMC 73
|
| S. Dilks
|
| Vol #:
|
| 2
|
|
|
| EMC 74
|
| L. Crosby
|
| Vol #:
|
| 2
|
|
|
| EMC 75
|
| Susan
|
| Vol #:
|
| 2
|
|
|
| EMC 76
|
| Dr. M. Thoennes
|
| Vol #:
|
| 2
|
|
|
| EMC 77
|
| M. Ortega
|
| Vol #:
|
| 2
|
|
|
| EMC 78
|
| J. Stuart
|
| Vol #:
|
| 2
|
|
|
| EMC 79
|
| V. Walton
|
| Vol #:
|
| 2
|
|
|
| EMC 80
|
| S. Scheckner, DMD
|
| Vol #:
|
| 2
|
|
|
| EMC 81
|
| Y. Tal
|
| Vol #:
|
| 2
|
|
|
| EMC 82
|
| K. Peterson
|
| Vol #:
|
| 2
|
|
|
| EMC 83
|
| J. Marich
|
| Vol #:
|
| 2
|
|
|
| EMC 84
|
| E. BRandt
|
| Vol #:
|
| 2
|
|
|
| EMC 85
|
| J. Marich
|
| Vol #:
|
| 2
|
|
|
| EMC 86
|
| D. MArtin
|
| Vol #:
|
| 2
|
|
|
| EMC 87
|
| C. Spencer
|
| Vol #:
|
| 2
|
|
|
| EMC 88
|
| T. White
|
| Vol #:
|
| 2
|
|
|
| EMC 89
|
| B. Shands
|
| Vol #:
|
| 2
|
|
|
| EMC 90
|
| C. Geyer, RDH
|
| Vol #:
|
| 2
|
|
|
| EMC 91
|
| J. Schaefer
|
| Vol #:
|
| 2
|
|
|
| EMC 92
|
| L. George
|
| Vol #:
|
| 2
|
|
|
| EMC 93
|
| B. Scott, RDH
|
| Vol #:
|
| 2
|
|
|
| EMC 94
|
| S. Kreider, MSIT, RN, CPC
|
| Vol #:
|
| 2
|
|
|
| EMC 95
|
| J. Parfitt
|
| Vol #:
|
| 2
|
|
|
| 2006P-0114
|
| Refrain from taking administrative action regarding approval and/or effective date of final approval of any and all ANDAs for a generic version of Metrogel-Vaginal 0.75%
|
|
|
| EC 1
|
| Mr. Dave Lowe
|
| Vol #:
|
| 2
|
|
|
| 2006P-0151
|
| Stay the current approvable letter with conditions of any and all Premarket Applications for silicone gel-filled breast implants
|
|
|
| EC 720
|
| Mrs. tracy sutton
|
| Vol #:
|
| 3
|
|
|
| 2006P-0158
|
| Revoke regulations that provided for the inclusion and addition of sucralose as a non-nutritive sweetener in food
|
|
|
| EC 1
|
| McNeil Nutritionals, LLC
|
| Vol #:
|
| 1
|
|
|
| 2006P-0186
|
| Withdraw new drug application (NDA 21-179) for Renagel Tablets (sevelamer hydrochloride) 400 and 800 mg
|
|
|
| EC 2
|
| Mr. Dave Lowe
|
| Vol #:
|
| 1
|
|
|
| 2006P-0223
|
| Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for
|
|
| | | | | | | | |
|
|
| filing an ANDA
|
|
|
| EC 580
|
| Mr. Glen Stremel
|
| Vol #:
|
| 5
|
|
|
| EC 581
|
| Mr. David Knebelsberger
|
| Vol #:
|
| 5
|
|
|
| EC 582
|
| Dr. theresa mccall
|
| Vol #:
|
| 5
|
|
|
| EC 583
|
| Dr. Larissa Meyer
|
| Vol #:
|
| 5
|
|
|
| EC 584
|
| Mr. Michael Falcone
|
| Vol #:
|
| 5
|
|
|
| EC 585
|
| Mrs. Susan Calhoun
|
| Vol #:
|
| 5
|
|
|
| EC 586
|
| Mr. Steve Bowman
|
| Vol #:
|
| 5
|
|
|
| 2006P-0310
|
| Compel the Agency to follow requirements of the Drug Listing Act of 1972
|
|
|
| EC 1
|
| Mr. Dave Lowe
|
| Vol #:
|
| 1
|
|
|
| 2006P-0346
|
| Ban Marketing of Estratest, Estratest H.S. and Syntest D.S. and Syntest H.S. associated with Menopause
|
|
|
| EC 1
|
| Mr. Dave Lowe
|
| Vol #:
|
| 1
|
|
|
| 2006P-0360
|
| Determine that the discontinued formulation of Carbocaine Injection, 3% supplied in 1.8 mL cartridge was not discontinued for safety and efficacy reasons
|
|
|
| EC 2
|
| Mr. Dave Lowe
|
| Vol #:
|
| 1
|
|
|
| 2006P-0364
|
| Reformulation of central nervous system (CNS) stimulant drugs
|
|
|
| EC 1
|
| Mr. Dave Lowe
|
| Vol #:
|
| 1
|
|
|
| 2006P-0365
|
| Citizen Petition Urging FDA to Take Regulatory Action to Safeguard the Public from Violative Dental Devices Distributed by Five Companies, Including Devices Manufactured in Unregistered Facilities and
|
|
|
|
|
|
|
| ACK 1
|
| FDA/DDM to Kerr Corporation
|
| Vol #:
|
| 1
|
|
|
| CP 1
|
| Kerr Corporation
|
| Vol #:
|
| 1
|
|
|